- Capricor Therapeutics press release (NASDAQ:CAPR): Q2 GAAP EPS of -$0.29 misses by $0.03.
- As of June 30, 2022, the Company’s cash, cash equivalents and marketable securities totaled approximately $51.4 million, compared to approximately $34.9 million on December 31, 2021.
- No shares were sold under the Company’s at-the-market program in the second quarter of 2022.
- Shares -2.65%.
Capricor Therapeutics GAAP EPS of -$0.29 misses by $0.03
Recommended For You
More Trending News
About CAPR Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| CAPR | - | - |
| Capricor Therapeutics, Inc. | ||